[Features of steroidogenesis and arterial hypertension in men in different types of "physiological" male hyperandrogenism]. [PDF]
Probl Endokrinol (Mosk), 2023 Filatova VA +6 more
europepmc +1 more source
[Main epidemiological indicators of type 1 diabetes mellitus in children in the Russian Federation for 2014-2023]. [PDF]
Probl Endokrinol (Mosk)Laptev DN +7 more
europepmc +1 more source
[Highly selective sodium-glucose co-transporter type 2 inhibitor empagliflozin as means of brain protection in conditions of chronic brain dyscirculation]. [PDF]
Probl Endokrinol (Mosk)Simanenkova AV +7 more
europepmc +1 more source
[Vitamin D deficiency in overweight patients: current strategies and practical aspects]. [PDF]
Probl Endokrinol (Mosk)Karonova TL +13 more
europepmc +1 more source
[Multiplex analysis of post-Covid cardiorenal complications in patients with type 1 and type 2 diabetes mellitus according to the mobile diagnostic and treatment center (Diamobil)]. [PDF]
Probl Endokrinol (Mosk)Vikulova OК +15 more
europepmc +1 more source
[Clinical case of plurihormonal pituitary adenoma (STH/ACTH/TSH/FSH/LH-secreting), diagnostic pitfalls]. [PDF]
Probl Endokrinol (Mosk)Kostyleva DN +6 more
europepmc +1 more source
[Cognitive impairment in patients with obesity and impaired carbohydrate metabolism (dysglycemia)]. [PDF]
Probl Endokrinol (Mosk)Dzgoeva FK, Ekusheva EV, Demidova VV.
europepmc +1 more source
[Pituitary disorders in patients with end-stage chronic renal failure]. [PDF]
Probl Endokrinol (Mosk)Markova TN, Kosova EV, Mishchenko NK.
europepmc +1 more source
[The history of the pharmacotherapy of obesity]. [PDF]
Probl Endokrinol (Mosk)Berkovskaya MA +3 more
europepmc +1 more source
[Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis]. [PDF]
Probl Endokrinol (Mosk)Ermolaeva AS, Fadeev VV.
europepmc +1 more source